献血不良反应监测进展*

doi:10.3969/j.issn.1671-2587.2020.05.028

临床输血与检验 ›› 2020, Vol. 22 ›› Issue (5): 556-560.DOI: 10.3969/j.issn.1671-2587.2020.05.028

• 综述 • 上一篇

献血不良反应监测进展^*

杨俊鸿, 黄霞, 何涛, 李小红

400015 重庆市血液中心

收稿日期:2019-03-22 出版日期:2020-10-20 发布日期:2020-10-16
通讯作者: 李小红,女,副主任技师,硕士,主要从事输血安全研究,（E-mail）496193324@qq.com。
作者简介:杨俊鸿（1987-）,男,重庆人,主管技师,硕士,主要从事血液质量控制和血液安全监测研究,（Tel）023-89887331 （E-mail）yangjunhong2013@163.com。
基金资助:
*本课题受重庆市卫生计生委重点项目（No.2016ZDXM-035）、中国输血协会威高基金（No.CSBT-WG-2019-02）资助

Research Progress of Heamovigilance in Adverse Reaction of Blood Donation

YANG Jun-hong, HUANG Xia, HE Tao, et al

Chongqing Blood Center, Chongqing 400015

Received:2019-03-22 Online:2020-10-20 Published:2020-10-16

摘要/Abstract

摘要： 随着输血医学的发展,献血者的健康越来越受到关注。为了做好献血者献血不良反应监测,不同国家和地区相继制定了献血不良反应监测标准,系统性或区域性地开展献血不良反应监测,研究其发生率及发生机制,用于预防和处置献血不良反应。本文就国内外已报道的部分无偿献血者献血不良反应的监测标准、数据获取方式、不良反应发生率及其相关因素、对献血者保留的影响以及预防和处理等方面的内容进行综合分析,为采供血机构及相关部门认识献血不良反应,并开展相关预防和控制工作提供科学依据。

关键词: 献血不良反应, 血液安全监测, 献血者安全

Abstract: With the development of blood transfusion medicine, more and more attention has been paid to the health of donors. In order to monitor the adverse reactions of blood donors, many countries and regions have formulated the vigilance standards for the adverse reactions of blood donation. They have carried out the vigilance of the adverse reactions of blood donation systematically, and studied the incidence rate and occurrence mechanism for the prevention and disposal of the adverse reactions of blood donation. In our review, we summarized vigilance standards, data access, incidence of adverse reactions, the related factors and the influence of blood donation adverse reaction and analyzed the measures of prevention and treatment of adverse reactions. It provides scientific basis for the blood collecting and supplying institutions and related departments to understand the adverse reactions of blood donation and carry out related prevention and control adverse reactions of blood donation.

Key words: Adverse reactions to blood donation, Heamovigilance, Donor safety

中图分类号:

R457.1

杨俊鸿, 黄霞, 何涛, 李小红. 献血不良反应监测进展^*[J]. 临床输血与检验, 2020, 22(5): 556-560.

YANG Jun-hong, HUANG Xia, HE Tao, et al. Research Progress of Heamovigilance in Adverse Reaction of Blood Donation[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 556-560.

参考文献

[1] 陈辉,徐健,郭瑾,等.国家卫生行业标准《献血不良反应分类指南》导读[J].中国输血杂志,2017,30(9):1080-1084.
[2] 范亚欣,吴洁玲,孟庆丽,等.全国献血不良反应的调查与分析[J]. 中国输血杂志,2016,29(9):956-959.
[3] 高波,周源,李永铭,等.我国献血不良反应监测管理现状[J]. 中国输血杂志,2018,31(9):974-977.
[4] 崔伟慧. 献血不良反应对献血者再次献血的影响及护理要点分析[J].中国医药指南,2017,15(32):246-247.
[5] 中国输血协会血液质量管理工作委员会.血液安全预警指南(第二版)[S].2015.
[6] 国家卫生计生委.献血不良反应分类指南[S].WS/T 571-2017.
[7] 国家卫生计生委. 献血相关血管迷走神经反应预防和处置指南[S]. WS/T 595-2018.
[8] Working Group on Donor Vigilance of the International Society of Blood Transfusion,Working Party on Haemovigilance,in collaboration with The International Haemovigilance Network and The AABB Donor Haemovigilance Working Group. Standard forsurveillance of complications related to blood donatio[S].2014-12-11[2014-12-25].. Standard forsurveillance of complications related to blood donatio[S].2014-12-11[2014-12-25].http://www.isbtweb.org/working-parties/haemovigilance/definitions.
[9] Goldman M,Land K,Robillard P,et al.Development of standard definitions for surveillance of complications related to blood donation[J].Vox Sang,2016,110(2):185-188.
[10] 郭永建. 国际输血协会献血并发症监测标准(2014年修订版)主要内容及其启示[J].中国输血杂志,2015,28(2):223-229.
[11] 中国输血协会血液质量管理工作委员会.血液安全预警指南(第一版)[S].2013.
[12] 中国输血协会. 血液安全监测指南[S].T/CSBT 001-2019.
[13] Daurat A,Roger C,Gris J,et al.Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors:a study from French hemovigilance data[J]. Transfusion,2016,56(6):1295-1303.
[14] Eder AF,Dy BA,Kennedy JM,et al.The American Red Cross donor hemovigilance program:complications of blood donation reported in 2006[J]. Transfusion,2008,48(9):1809-1819.
[15] Affiliated to the Royal College of Pathologists.The2017 Annual SHOT Report[EB/OL]. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2017-WEB-Final-v4-25-9-18.pdf.
[16] Inaba S,Takanashi M,Matsuzaki K,et al.Analysis of a questionnaire on adverse reactions to blood donation in Japan[J]. Transfus Apher Sci,2013,48(1):21-34.
[17] Newman BH,Newman DT,Ahmad R,et al.The effect of whole-blood donor adverse events on blood donor return rates[J]. Transfusion,2006,46(8):1374-1379.
[18] Tiwari AK,Aggarwal G,Dara RC,et al.Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions:First attempt in India[J]. Transfus Apher Sci, 2017,56(2):141-146.
[19] Burkhardt T,Dimanski B,Karl R,et al.Donor vigilance data of a blood transfusion service:a multicenter analysis[J]. Transfus Apher Sci,2015,53(2):180-184.
[20] Politis C,Wiersum JC,Richardson C,et al.The international haemovigilance network database for the surveillance of adverse reactions and events in donors and recipients of blood components:technical issues and results[J]. Vox Sang,2016,111(4):409-417.
[21] Jorgensen J,Sorensen BS.Donor vigilance[J]. ISBT Sci Ser, 2008,3(1):48-53.
[22] Newman BH,Newman DT,Ahmad R,et al.The effect of whole-blood donor adverse events on blood donor return rates[J]. Transfusion,2006,46(8):1374-1379.
[23] Sultan S,Baig MA,Irfan SM,et al.Adverse reactions in allogeneic blood donors:a tertiary care experience from a developing country[J].Oman Med J,2016,31(2):124-128.
[24] Rajbhandary S, Stubbs JR, Land KJ, Whitaker BI (eds).AABB Donor Hemovigilance Report: 2012-2014 on behalf of the AABB US Donor Hemovigilance Working Group [EB/OL].AABB Press, 2016. http://www.aabb.org/research/hemovigilance/Documents/2012-2014-AABB-Donor-Hemovigilance-Report.pdf.
[25] Unidad de Hemovigilancia.HEMOVIGILANCIA AÑO 2016 [EB/OL]. 2017. http://www.msssi.gob.es/profesionales/saludPublica/medicinaTransfusional/hemovigilancia/docs/IInform2016.pdf.
[26] Australian Haemovigilance Report, Data for2013-14 published by the National Blood Authority [EB/OL].2016. https://www.blood.gov.au/system/files/Australian-Haemovigilance-Report-2016.pdf.
[27] Krishna Badami,John Dagger,William Murphy,et al. Annual Report2015 [EB/OL].2016. https://www.nzblood.co.nz/assets/Uploads/Haemovigilance-Annual-Report-2016.pdf.
[28] Jackie Thomson,Gregory Bellairs,Caroline Hilton, et al.SANBS & WPBTS Haemovigilance Report2016 [EB/OL].2016.https://sanbs.org.za/wp-content/uploads/2017/12/SANBS-HV-Report_2016_Web-Version.pdf.
[29] Eder AF,Hillyer CD,Dy BA,et al.Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds[J]. JAMA,2008,299(19):2279-2286.
[30] Kamel H,Tomasulo P,Bravo M,et al.Delayed adverse reactions to blood donation[J]. Transfusion,2010,50(3):556-565.
[31] Wiltbank TB,Giordano GF,Kamel H,et al.Faint and prefaint reactions in whole-blood donors:an analysis of predonation measurements and their predictive value[J]. Transfusion,2008,48(9):1799-1808.
[32] Hanson SA,France CR.Predonation water ingestion attenuates negative reactions to blood donation[J]. Transfusion,2004,44(6):924-928.
[33] Sauer LA.Caffeine attenuates vasovagal reactions in female first-time blood donors[J].Heal Psychol,1999,18(4):403-409.
[34] Ditto B,France CR,Lavoie P,et al.Reducing reactions to blood donation with applied muscle tension:a randomized controlled trial[J]. Transfusion,2003,43(9):1269-1275.
[35] Custer B,Rios JA,Schlumpf K,et al.Adverse reactions and other factors that impact subsequent blood donation visits[J]. Transfusion,2012,52(1):118-126.
[36] Masser BM,White KM,Terry DJ.Beliefs underlying the intention to donate again among first-time blood donors who experience a mild adverse event[J]. Transfus Apher Sci,2013,49(2):278-284.
[37] 国家卫生健康委员会办公厅.关于2017年全国血液安全技术核查情况的通报[EB/OL].国卫办医函〔2018〕346号. http://www.nhfpc.gov.cn/yzygj/s7658/201805/77ba80726c694b188e617f0d43d23856.shtml.

献血不良反应监测进展^*

Research Progress of Heamovigilance in Adverse Reaction of Blood Donation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们